Cancer Research CTRC-AACR San Antonio Breast Cancer Symposium AACR Conference on Molecular Diagnostics - 2008
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
Cancer Research Clinical Cancer Research
Cancer Epidemiology Biomarkers & Prevention Molecular Cancer Therapeutics
Molecular Cancer Research Cancer Prevention Research
Cancer Prevention Journals Portal Cancer Reviews Online
Annual Meeting Education Book Cell Growth & Differentiation
[Cancer Research 57, 1735-1742, May 1, 1997]
© 1997 American Association for Cancer Research
This Article
Right arrow Full Text (PDF)
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrow reprints & permissions
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Guo, N.-h.
Right arrow Articles by Roberts, D. D.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Guo, N.-h.
Right arrow Articles by Roberts, D. D.

Thrombospondin 1 and Type I Repeat Peptides of Thrombospondin 1 Specifically Induce Apoptosis of Endothelial Cells1

Neng-hua Guo, Henry C. Krutzsch, John K. Inman and David D. Roberts2

Laboratory of Pathology, National Cancer Institute [N-h. G., H. C. K., D. D. R.], and National Institute of Allergy and Infectious Diseases [J. K. I.], NIH, Bethesda, Maryland 20892-1500

Thrombospondin 1 (TSP1) inhibits angiogenesis and modulates endothelial cell adhesion, motility, and growth. The antiproliferative activity of TSP1 is mimicked by synthetic peptides derived from the type I repeats of TSP1 that antagonize fibroblast growth factor 2 and activate latent transforming growth factor ß. These TSP1 analogues induced programmed cell death in bovine aortic endothelial cells based on morphological changes, assessment of DNA fragmentation, and internucleosomal DNA cleavage. Intact TSP1 also induced DNA fragmentation. The endothelial cell response was specific because no DNA fragmentation was induced in MDA-MB-435S breast carcinoma cells, although TSP1 and the peptide conjugates inhibited the growth of both cell types. Apoptosis did not depend on activation of latent transforming growth factor ß because peptides lacking the activating sequence RFK were active. Apoptosis was not sensitive to inhibitors of ceramide generation but was inhibited by the phosphatase inhibitor vanadate. Induction of DNA fragmentation by the peptides was decreased when endothelial cell cultures reached confluence. Growth of the cells on a fibronectin substrate also suppressed induction of apoptosis by TSP1 or the peptides. Differential sensitivities to kinase inhibitors suggest that apoptosis and inhibition of proliferation are mediated by distinct signal transduction pathways. These results demonstrate that induction of apoptosis by the TSP1 analogues is not a general cytotoxic effect and is conditional on a lack of strong survival-promoting signals, such as those provided by a fibronectin matrix. The antitumor activity of TSP1 may therefore result from an increased sensitivity to apoptosis in endothelial cells adjacent to a provisional matrix during formation of vascular beds in tumors expressing TSP1.

1 Supported in part by Department of Defense Grant DAMD17-94-J-4499. The content of this article does not necessarily reflect the position or the policy of the government, and no official endorsement should be inferred.

2 To whom requests for reprints should be addressed, at Building 10, Room 2A33, 10 Center Drive MSC 1500, Bethesda, MD 20892-1500. Phone: (301) 496-6264; Fax: (301) 402-0043.

Received 10/ 7/96. Accepted 3/ 8/97.




This article has been cited by other articles:


Home page
 EndocrinologyHome page
H. Liu, R. Yang, B. Tinner, A. Choudhry, N. Schutze, and B. Chaqour
Cysteine-Rich Protein 61 and Connective Tissue Growth Factor Induce Deadhesion and Anoikis of Retinal Pericytes
Endocrinology, April 1, 2008; 149(4): 1666 - 1677.
[Abstract] [Full Text] [PDF]

Home page
 HypertensionHome page
Y. Iwazu, S. Muto, G. Fujisawa, E. Nakazawa, K. Okada, S. Ishibashi, and E. Kusano
Spironolactone Suppresses Peritubular Capillary Loss and Prevents Deoxycorticosterone Acetate/Salt-Induced Tubulointerstitial Fibrosis
Hypertension, March 1, 2008; 51(3): 749 - 754.
[Abstract] [Full Text] [PDF]

Home page
 Mol. Biol. CellHome page
A. Oganesian, L. C. Armstrong, M. M. Migliorini, D. K. Strickland, and P. Bornstein
Thrombospondins Use the VLDL Receptor and a Nonapoptotic Pathway to Inhibit Cell Division in Microvascular Endothelial Cells
Mol. Biol. Cell, February 1, 2008; 19(2): 563 - 571.
[Abstract] [Full Text] [PDF]

Home page
 EndocrinologyHome page
F. H. Thomas, H. Wilson, A. Silvestri, and H. M. Fraser
Thrombospondin-1 Expression Is Increased during Follicular Atresia in the Primate Ovary
Endocrinology, January 1, 2008; 149(1): 185 - 192.
[Abstract] [Full Text] [PDF]

Home page
 Arch SurgHome page
D. M. Iddings, E. A. Koda, S. S. Grewal, R. Parker, S. Saha, and A. Bilchik
Association of Angiogenesis Markers With Lymph Node Metastasis in Early Colorectal Cancer
Arch Surg, August 1, 2007; 142(8): 738 - 745.
[Abstract] [Full Text] [PDF]

Home page
 Arch DermatolHome page
S. Q. Wang and L. H. Goldberg
Pulsed-Dye Laser Treatment of Nonhealing Chronic Ulcer With Hypergranulation Tissue
Arch Dermatol, June 1, 2007; 143(6): 700 - 702.
[Full Text] [PDF]

Home page
 Circ. Res.Home page
I. Staniszewska, S. Zaveri, L. D. Valle, I. Oliva, V. L. Rothman, S. E. Croul, D. D. Roberts, D. F. Mosher, G. P. Tuszynski, and C. Marcinkiewicz
Interaction of {alpha}9{beta}1 Integrin With Thrombospondin-1 Promotes Angiogenesis
Circ. Res., May 11, 2007; 100(9): 1308 - 1316.
[Abstract] [Full Text] [PDF]

Home page
 Mol Cancer ResHome page
I. Stasinopoulos, D. R. O'Brien, F. Wildes, K. Glunde, and Z. M. Bhujwalla
Silencing of Cyclooxygenase-2 Inhibits Metastasis and Delays Tumor Onset of Poorly Differentiated Metastatic Breast Cancer Cells
Mol. Cancer Res., May 1, 2007; 5(5): 435 - 442.
[Abstract] [Full Text] [PDF]

Home page
 J. Biol. Chem.Home page
P. Raman, I. Krukovets, T. E. Marinic, P. Bornstein, and O. I. Stenina
Glycosylation Mediates Up-regulation of a Potent Antiangiogenic and Proatherogenic Protein, Thrombospondin-1, by Glucose in Vascular Smooth Muscle Cells
J. Biol. Chem., February 23, 2007; 282(8): 5704 - 5714.
[Abstract] [Full Text] [PDF]

Home page
 Genes Dev.Home page
R. van Amerongen and A. Berns
TXR1-mediated thrombospondin repression: a novel mechanism of resistance to taxanes?
Genes & Dev., August 1, 2006; 20(15): 1975 - 1981.
[Full Text] [PDF]

Home page
 Cancer Res.Home page
A. R. Albig, J. R. Neil, and W. P. Schiemann
Fibulins 3 and 5 Antagonize Tumor Angiogenesis In vivo.
Cancer Res., March 1, 2006; 66(5): 2621 - 2629.
[Abstract] [Full Text] [PDF]

Home page
 J. Am. Soc. Nephrol.Home page
K. M.A. Rouschop, N. Claessen, S. T. Pals, J. J. Weening, and S. Florquin
CD44 Disruption Prevents Degeneration of the Capillary Network in Obstructive Nephropathy via Reduction of TGF-beta1-Induced Apoptosis
J. Am. Soc. Nephrol., March 1, 2006; 17(3): 746 - 753.
[Abstract] [Full Text] [PDF]

Home page
 Cancer Res.Home page
C. Y. Fears, J. R. Grammer, J. E. Stewart Jr., D. S. Annis, D. F. Mosher, P. Bornstein, and C. L. Gladson
Low-Density Lipoprotein Receptor-Related Protein Contributes to the Antiangiogenic Activity of Thrombospondin-2 in a Murine Glioma Model
Cancer Res., October 15, 2005; 65(20): 9338 - 9346.
[Abstract] [Full Text] [PDF]

Home page
 Neuro OncolHome page
T. A. Rege, C. Y. Fears, and C. L. Gladson
Endogenous inhibitors of angiogenesis in malignant gliomas: Nature's antiangiogenic therapy
Neuro-oncol, April 1, 2005; 7(2): 106 - 121.
[Abstract] [PDF]

Home page
 Mol Cancer ResHome page
H. Huang, S. C. Campbell, D. F. Bedford, T. Nelius, D. Veliceasa, E. H. Shroff, J. Henkin, A. Schneider, N. Bouck, and O. V. Volpert
Peroxisome Proliferator-Activated Receptor {gamma} Ligands Improve the Antitumor Efficacy of Thrombospondin Peptide ABT510
Mol. Cancer Res., October 1, 2004; 2(10): 541 - 550.
[Abstract] [Full Text] [PDF]

Home page
 Am. J. Pathol.Home page
K. O. Yee, M. Streit, T. Hawighorst, M. Detmar, and J. Lawler
Expression of the Type-1 Repeats of Thrombospondin-1 Inhibits Tumor Growth Through Activation of Transforming Growth Factor-{beta}
Am. J. Pathol., August 1, 2004; 165(2): 541 - 552.
[Abstract] [Full Text] [PDF]

Home page
 Cancer Res.Home page
A. Thomas-Tikhonenko, I. Viard-Leveugle, M. Dews, P. Wehrli, C. Sevignani, D. Yu, S. Ricci, W. el-Deiry, B. Aronow, G. Kaya, et al.
Myc-Transformed Epithelial Cells Down-Regulate Clusterin, Which Inhibits Their Growth in Vitro and Carcinogenesis in Vivo
Cancer Res., May 1, 2004; 64(9): 3126 - 3136.
[Abstract] [Full Text] [PDF]

Home page
 Circ. Res.Home page
M. J. Calzada, L. Zhou, J. M. Sipes, J. Zhang, H. C. Krutzsch, M. L. Iruela-Arispe, D. S. Annis, D. F. Mosher, and D. D. Roberts
{alpha}4{beta}1 Integrin Mediates Selective Endothelial Cell Responses to Thrombospondins 1 and 2 In Vitro and Modulates Angiogenesis In Vivo
Circ. Res., March 5, 2004; 94(4): 462 - 470.
[Abstract] [Full Text] [PDF]

Home page
 Cancer Res.Home page
P. P. Manna and W. A. Frazier
CD47 Mediates Killing of Breast Tumor Cells via Gi-Dependent Inhibition of Protein Kinase A
Cancer Res., February 1, 2004; 64(3): 1026 - 1036.
[Abstract] [Full Text] [PDF]

Home page
 Proc. Natl. Acad. Sci. USAHome page
G. Bocci, G. Francia, S. Man, J. Lawler, and R. S. Kerbel
Thrombospondin 1, a mediator of the antiangiogenic effects of low-dose metronomic chemotherapy
PNAS, October 28, 2003; 100(22): 12917 - 12922.
[Abstract] [Full Text] [PDF]

Home page
 CirculationHome page
O. I. Stenina, I. Krukovets, K. Wang, Z. Zhou, F. Forudi, M. S. Penn, E. J. Topol, and E. F. Plow
Increased Expression of Thrombospondin-1 in Vessel Wall of Diabetic Zucker Rat
Circulation, July 1, 2003; 107(25): 3209 - 3215.
[Abstract] [Full Text] [PDF]

Home page
 Clin. Cancer Res.Home page
Y. Miyata, S. Koga, K. Takehara, H. Kanetake, and S. Kanda
Expression of Thrombospondin-derived 4N1K Peptide-containing Proteins in Renal Cell Carcinoma Tissues Is Associated with a Decrease in Tumor Growth and Angiogenesis
Clin. Cancer Res., May 1, 2003; 9(5): 1734 - 1740.
[Abstract] [Full Text] [PDF]

Home page
 Biol. Reprod.Home page
J. J. Petrik, P. A. Gentry, J.-J. Feige, and J. LaMarre
Expression and Localization of Thrombospondin-1 and -2 and Their Cell-Surface Receptor, CD36, During Rat Follicular Development and Formation of the Corpus Luteum
Biol Reprod, November 1, 2002; 67(5): 1522 - 1531.
[Abstract] [Full Text] [PDF]

Home page
 J. Am. Soc. Nephrol.Home page
E. P. Bottinger and M. Bitzer
TGF-{beta} Signaling in Renal Disease
J. Am. Soc. Nephrol., October 1, 2002; 13(10): 2600 - 2610.
[Abstract] [Full Text] [PDF]

Home page
 Molecular Cancer TherapeuticsHome page
D. Boivin, S. Gendron, E. Beaulieu, D. Gingras, and R. Beliveau
The Antiangiogenic Agent Neovastat (Ae-941) Induces Endothelial Cell Apoptosis
Mol. Cancer Ther., August 1, 2002; 1(10): 795 - 802.
[Abstract] [Full Text] [PDF]

Home page
 Mol. Biol. CellHome page
L. C. Armstrong, B. Bjorkblom, K. D. Hankenson, A. W. Siadak, C. E. Stiles, and P. Bornstein
Thrombospondin 2 Inhibits Microvascular Endothelial Cell Proliferation by a Caspase-independent Mechanism
Mol. Biol. Cell, June 1, 2002; 13(6): 1893 - 1905.
[Abstract] [Full Text] [PDF]

Home page
 J. Immunol.Home page
Z. O-Quan Shi, M. J. Fischer, G. T. De Sanctis, M. R. Schuyler, and Y. Tesfaigzi
IFN-{gamma}, But Not Fas, Mediates Reduction of Allergen-Induced Mucous Cell Metaplasia by Inducing Apoptosis
J. Immunol., May 1, 2002; 168(9): 4764 - 4771.
[Abstract] [Full Text] [PDF]

Home page
 Proc. Natl. Acad. Sci. USAHome page
J. Tran, Z. Master, J. L. Yu, J. Rak, D. J. Dumont, and R. S. Kerbel
A role for survivin in chemoresistance of endothelial cells mediated by VEGF
PNAS, April 2, 2002; 99(7): 4349 - 4354.
[Abstract] [Full Text] [PDF]

Home page
 J. Am. Soc. Nephrol.Home page
D.-H. Kang, J. Kanellis, C. Hugo, L. Truong, S. Anderson, D. Kerjaschki, G. F. Schreiner, and R. J. Johnson
Role of the Microvascular Endothelium in Progressive Renal Disease
J. Am. Soc. Nephrol., March 1, 2002; 13(3): 806 - 816.
[Abstract] [Full Text] [PDF]

Home page
 INT J SURG PATHOLHome page
S.-i. Aishima, K.-i. Taguchi, K. Sugimachi, Y. Asayama, H. Nishi, M. Shimada, K. Sugimachi, and M. Tsuneyoshi
The Role of Thymidine Phosphorylase and Thrombospondin-1 in Angiogenesis and Progression of Intrahepatic Cholangiocarcinoma
International Journal of Surgical Pathology, January 1, 2002; 10(1): 47 - 56.
[Abstract] [PDF]

Home page
 Ann. N. Y. Acad. Sci.Home page
Y. SATO, K. TERUYAMA, T. NAKANO, N. ODA, M. ABE, K. TANAKA, and C. IWASAKA-YAGI
Role of Transcription Factors in Angiogenesis: Ets-1 Promotes Angiogenesis As Well As Endothelial Apoptosis
Ann. N.Y. Acad. Sci., December 1, 2001; 947(1): 117 - 123.
[Abstract] [Full Text] [PDF]

Home page
 Cancer Res.Home page
W.-M. Miao, W. Lin Seng, M. Duquette, P. Lawler, C. Laus, and J. Lawler
Thrombospondin-1 Type 1 Repeat Recombinant Proteins Inhibit Tumor Growth through Transforming Growth Factor-{beta}-dependent and -independent Mechanisms
Cancer Res., November 1, 2001; 61(21): 7830 - 7839.
[Abstract] [Full Text] [PDF]

Home page
 Am. J. Pathol.Home page
J. Lawler, W.-M. Miao, M. Duquette, N. Bouck, R. T. Bronson, and R. O. Hynes
Thrombospondin-1 Gene Expression Affects Survival and Tumor Spectrum of p53-Deficient Mice
Am. J. Pathol., November 1, 2001; 159(5): 1949 - 1956.
[Abstract] [Full Text] [PDF]

Home page
 Proc. Natl. Acad. Sci. USAHome page
J. C. Rodriguez-Manzaneque, T. F. Lane, M. A. Ortega, R. O. Hynes, J. Lawler, and M. L. Iruela-Arispe
Thrombospondin-1 suppresses spontaneous tumor growth and inhibits activation of matrix metalloproteinase-9 and mobilization of vascular endothelial growth factor
PNAS, October 12, 2001; (2001) 171460498.
[Abstract] [Full Text] [PDF]

Home page
 Am. J. Pathol.Home page
T. R. Kyriakides, Y.-H. Zhu, Z. Yang, G. Huynh, and P. Bornstein
Altered Extracellular Matrix Remodeling and Angiogenesis in Sponge Granulomas of Thrombospondin 2-Null Mice
Am. J. Pathol., October 1, 2001; 159(4): 1255 - 1262.
[Abstract] [Full Text]

Home page
 J. Am. Soc. Nephrol.Home page
D.-H. KANG, A. H. JOLY, S.-W. OH, C. HUGO, D. KERJASCHKI, K. L. GORDON, M. MAZZALI, J. A. JEFFERSON, J. HUGHES, K. M. MADSEN, et al.
Impaired Angiogenesis in the Remnant Kidney Model: I. Potential Role of Vascular Endothelial Growth Factor and Thrombospondin-1
J. Am. Soc. Nephrol., July 1, 2001; 12(7): 1434 - 1447.
[Abstract] [Full Text] [PDF]

Home page
 Clin. Cancer Res.Home page
R. Mehta, A. Kyshtoobayeva, T. Kurosaki, E. J. Small, H. Kim, R. Stroup, C. E. McLaren, K.-T. Li, and J. P. Fruehauf
Independent Association of Angiogenesis Index with Outcome in Prostate Cancer
Clin. Cancer Res., January 1, 2001; 7(1): 81 - 88.
[Abstract] [Full Text]

Home page
 Mol. Endocrinol.Home page
J.-F. Martini, C. Piot, L. M. Humeau, I. Struman, J. A. Martial, and R. I. Weiner
The Antiangiogenic Factor 16K PRL Induces Programmed Cell Death in Endothelial Cells by Caspase Activation
Mol. Endocrinol., October 1, 2000; 14(10): 1536 - 1549.
[Abstract] [Full Text]

Home page
 Circ. Res.Home page
S. Dimmeler and A. M. Zeiher
Endothelial Cell Apoptosis in Angiogenesis and Vessel Regression
Circ. Res., September 15, 2000; 87(6): 434 - 439.
[Abstract] [Full Text] [PDF]

Home page
 Mol. Biol. CellHome page
L. Chandrasekaran, C.-Z. He, H. Al-Barazi, H. C. Krutzsch, M. L. Iruela-Arispe, and D. D. Roberts
Cell Contact-dependent Activation of alpha 3beta 1 Integrin Modulates Endothelial Cell Responses to Thrombospondin-1
Mol. Biol. Cell, September 1, 2000; 11(9): 2885 - 2900.
[Abstract] [Full Text]

Home page
 IOVSHome page
A. Shafiee, J. S. Penn, H. C. Krutzsch, J. K. Inman, D. D. Roberts, and D. A. Blake
Inhibition of Retinal Angiogenesis by Peptides Derived from Thrombospondin-1
Invest. Ophthalmol. Vis. Sci., July 1, 2000; 41(8): 2378 - 2388.
[Abstract] [Full Text]

Home page
 J. Exp. Med.Home page
M. Tenan, G. Fulci, M. Albertoni, A.-C. Diserens, M.-F. Hamou, M. El Atifi-Borel, J.-J. Feige, M. S. Pepper, and E. G. Van Meir
Thrombospondin-1 Is Downregulated by Anoxia and Suppresses Tumorigenicity of Human Glioblastoma Cells
J. Exp. Med., May 15, 2000; 191(10): 1789 - 1798.
[Abstract] [Full Text] [PDF]

Home page
 Clin. Cancer Res.Home page
G. J. Brewer, R. D. Dick, D. K. Grover, V. LeClaire, M. Tseng, M. Wicha, K. Pienta, B. G. Redman, T. Jahan, V. K. Sondak, et al.
Treatment of Metastatic Cancer with Tetrathiomolybdate, an Anticopper, Antiangiogenic Agent: Phase I Study
Clin. Cancer Res., January 1, 2000; 6(1): 1 - 10.
[Abstract] [Full Text]

Home page
 J. Histochem. Cytochem.Home page
Q. Yan and E. H. Sage
SPARC, a Matricellular Glycoprotein with Important Biological Functions
J. Histochem. Cytochem., December 1, 1999; 47(12): 1495 - 1506.
[Full Text]

Home page
 J. Immunol.Home page
K. E. Wilson, Z. Li, M. Kara, K. L. Gardner, and D. D. Roberts
{beta}1 Integrin- and Proteoglycan-Mediated Stimulation of T Lymphoma Cell Adhesion and Mitogen-Activated Protein Kinase Signaling by Thrombospondin-1 and Thrombospondin-1 Peptides
J. Immunol., October 1, 1999; 163(7): 3621 - 3628.
[Abstract] [Full Text] [PDF]

Home page
 CirculationHome page
M. L. Iruela-Arispe, M. Lombardo, H. C. Krutzsch, J. Lawler, and D. D. Roberts
Inhibition of Angiogenesis by Thrombospondin-1 Is Mediated by 2 Independent Regions Within the Type 1 Repeats
Circulation, September 28, 1999; 100(13): 1423 - 1431.
[Abstract] [Full Text] [PDF]

Home page
 NEJMHome page
A. J. Singer and R. A.F. Clark
Cutaneous Wound Healing
N. Engl. J. Med., September 2, 1999; 341(10): 738 - 746.
[Full Text] [PDF]

Home page
 J. Biol. Chem.Home page
F. Vazquez, G. Hastings, M.-A. Ortega, T. F. Lane, S. Oikemus, M. Lombardo, and M. L. Iruela-Arispe
METH-1, a Human Ortholog of ADAMTS-1, and METH-2 Are Members of a New Family of Proteins with Angio-inhibitory Activity
J. Biol. Chem., August 13, 1999; 274(33): 23349 - 23357.
[Abstract] [Full Text] [PDF]

Home page
 J. Biol. Chem.Home page
J. M. Sipes, H. C. Krutzsch, J. Lawler, and D. D. Roberts
Cooperation between Thrombospondin-1 Type 1 Repeat Peptides and alpha vbeta 3 Integrin Ligands to Promote Melanoma Cell Spreading and Focal Adhesion Kinase Phosphorylation
J. Biol. Chem., August 6, 1999; 274(32): 22755 - 22762.
[Abstract] [Full Text] [PDF]

Home page
 Am. J. Pathol.Home page
J. Cinatl Jr., R. Kotchetkov, M. Scholz, J. Cinatl, J.-U. Vogel, P. H. Driever, and H. W. Doerr
Human Cytomegalovirus Infection Decreases Expression of Thrombospondin-1 Independent of the Tumor Suppressor Protein p53
Am. J. Pathol., July 1, 1999; 155(1): 285 - 292.
[Abstract] [Full Text] [PDF]

Home page
 BloodHome page
A. Solovey, L. Gui, S. Ramakrishnan, M. H. Steinberg, and R. P. Hebbel
Sickle Cell Anemia as a Possible State of Enhanced Anti-Apoptotic Tone: Survival Effect of Vascular Endothelial Growth Factor on Circulating and Unanchored Endothelial Cells
Blood, June 1, 1999; 93(11): 3824 - 3830.
[Abstract] [Full Text] [PDF]

Home page
 Cancer Res.Home page
L. Lozonschi, M. Sunamura, M. Kobari, S. Egawa, L. Ding, and S. Matsuno
Controlling Tumor Angiogenesis and Metastasis of C26 Murine Colon Adenocarcinoma by a New Matrix Metalloproteinase Inhibitor, KB-R7785, in Two Tumor Models
Cancer Res., March 1, 1999; 59(6): 1252 - 1258.
[Abstract] [Full Text] [PDF]

Home page
 Mol. Pharmacol.Home page
D. W. Dawson, O. V. Volpert, S. F. A. Pearce, A. J. Schneider, R. L. Silverstein, J. Henkin, and N. P. Bouck
Three Distinct D-Amino Acid Substitutions Confer Potent Antiangiogenic Activity on an Inactive Peptide Derived from a Thrombospondin-1 Type 1 Repeat
Mol. Pharmacol., February 1, 1999; 55(2): 332 - 338.
[Abstract] [Full Text]

Home page
 Am. J. Pathol.Home page
K. Suzuma, H. Takagi, A. Otani, H. Oh, and Y. Honda
Expression of Thrombospondin-1 in Ischemia-Induced Retinal Neovascularization
Am. J. Pathol., February 1, 1999; 154(2): 343 - 354.
[Abstract] [Full Text] [PDF]

Home page
 J. Immunol.Home page
R. I. Brezinschek, N. Oppenheimer-Marks, and P. E. Lipsky
Activated T Cells Acquire Endothelial Cell Surface Determinants During Transendothelial Migration
J. Immunol., February 1, 1999; 162(3): 1677 - 1684.
[Abstract] [Full Text] [PDF]

Home page
 Arch Otolaryngol Head Neck SurgHome page
J. Maddalozzo, C. A. Hughes, L. Huang, Y. Mu, J. Ludemann, and S. Crawford
High Angiogenic Activity in Cells Isolated From Cystic Hygroma: Role of bFGF
Arch Otolaryngol Head Neck Surg, January 1, 1999; 125(1): 45 - 48.
[Abstract] [Full Text] [PDF]

Home page
 Mol. Biol. CellHome page
N. Sheibani and W. A. Frazier
Down-Regulation of Platelet Endothelial Cell Adhesion Molecule-1 Results in Thrombospondin-1 Expression and Concerted Regulation of Endothelial Cell Phenotype
Mol. Biol. Cell, April 1, 1998; 9(4): 701 - 713.
[Abstract] [Full Text]

Home page
 J. Exp. Med.Home page
Y. Hashimoto, N. Shindo-Okada, M. Tani, Y. Nagamachi, K. Takeuchi, T. Shiroishi, H. Toma, and J. Yokota
Expression of the Elm1 Gene, a Novel Gene of the CCN (Connective Tissue Growth Factor, Cyr61/Cef10, and Neuroblastoma Overexpressed Gene) Family, Suppresses In Vivo Tumor Growth and Metastasis of K-1735 Murine Melanoma Cells
J. Exp. Med., February 2, 1998; 187(3): 289 - 296.
[Abstract] [Full Text] [PDF]

Home page
 J. Biol. Chem.Home page
R. G. Rodrigues, N.-h. Guo, L. Zhou, J. M. Sipes, S. B. Williams, N. S. Templeton, H. R. Gralnick, and D. D. Roberts
Conformational Regulation of the Fibronectin Binding and alpha 3beta 1 Integrin-mediated Adhesive Activities of Thrombospondin-1
J. Biol. Chem., July 20, 2001; 276(30): 27913 - 27922.
[Abstract] [Full Text] [PDF]

Home page
 Proc. Natl. Acad. Sci. USAHome page
V. Stellmach, S. E. Crawford, W. Zhou, and N. Bouck
Prevention of ischemia-induced retinopathy by the natural ocular antiangiogenic agent pigment epithelium-derived factor
PNAS, February 27, 2001; 98(5): 2593 - 2597.
[Abstract] [Full Text] [PDF]

Home page
 Proc. Natl. Acad. Sci. USAHome page
J. Tran, Z. Master, J. L. Yu, J. Rak, D. J. Dumont, and R. S. Kerbel
A role for survivin in chemoresistance of endothelial cells mediated by VEGF
PNAS, April 2, 2002; 99(7): 4349